UPDATE: Wedbush Downgrades MAP Pharma (MAPP) to Neutral, Notes Other Potential M&A Targets

Go back to UPDATE: Wedbush Downgrades MAP Pharma (MAPP) to Neutral, Notes Other Potential M&A Targets